<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/176289</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Microbiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling the emergence of antibiotic resistance in the environment: an analytical solution for the minimum selection concentration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1038-7635</contrib-id>
<name>
<surname>Greenfield</surname>
<given-names>Ben K.</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
<xref ref-type="corresp" rid="cor1">&#x0023;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaked</surname>
<given-names>Shanna</given-names>
</name>
<xref ref-type="aff" rid="a2">b</xref>
<xref ref-type="author-notes" rid="n1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marrs</surname>
<given-names>Carl F.</given-names>
</name>
<xref ref-type="aff" rid="a2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nelson</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="a3">c</xref>
<xref ref-type="author-notes" rid="n2">&#x2020;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raxter</surname>
<given-names>Ian</given-names>
</name>
<xref ref-type="aff" rid="a4">d</xref>
<xref ref-type="author-notes" rid="n3">&#x2020;&#x2020;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xi</surname>
<given-names>Chuanwu</given-names>
</name>
<xref ref-type="aff" rid="a3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McKone</surname>
<given-names>Thomas E.</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jolliet</surname>
<given-names>Olivier</given-names>
</name>
<xref ref-type="aff" rid="a3">c</xref>
</contrib>
<aff id="a1"><label>a</label><institution>Department of Environmental Health Sciences, University of California - Berkeley</institution>, CA, <country>USA</country></aff>
<aff id="a2"><label>b</label><institution>Department of Epidemiology, University of Michigan</institution>, Ann Arbor, MI, <country>USA</country></aff>
<aff id="a3"><label>c</label><institution>Department of Environmental Health Sciences, University of Michigan</institution>, Ann Arbor, MI, <country>USA</country></aff>
<aff id="a4"><label>d</label><institution>Department of Mathematicsd, University of Michigan</institution>, Ann Arbor, MI, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x0023;</label>Corresponding Author. Current Address: Biology Department and Environmental Sciences Program, Southern Illinois University &#x2013; Edwardsville, IL 62026, USA email: <email>begreen@siue.edu</email></corresp>
<fn fn-type="present-address" id="n1"><label>&#x002A;</label><p>Current address: Department of Physics and Astronomy, University of California, Los Angeles, CA, USA</p></fn>
<fn fn-type="present-address" id="n2"><label>&#x2020;</label><p>Current address: Department of Math and Computer Science, Lawrence Technological University, Southfield, MI, USA</p></fn>
<fn fn-type="present-address" id="n3"><label>&#x2020;&#x2020;</label><p>Current address: ArborMetrix, Inc., Ann Arbor, MI, USA</p></fn>
</author-notes>
<pub-date pub-type="epub">
<year>2017</year>
</pub-date>
<elocation-id>176289</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="176289.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Environmental antibiotic risk management requires an understanding of how subinhibitory antibiotic concentrations contribute to the spread of resistance. We develop a simple model of competition between sensitive and resistant bacterial strains to predict the minimum selection concentration (MSC), the lowest level of antibiotic at which resistant bacteria are selected. We present an analytical solution for the MSC based on the routinely measured minimum inhibitory concentration (MIC) and the selection coefficient (sc) that expresses fitness differences between strains. We calibrated the model by optimizing the shape of the bacterial growth dose&#x2013;response curve to antibiotic or metal exposure (the Hill coefficient, &#x03BA;) to fit previously published experimental growth rate difference data. The model fit varied among nine compound-taxa combinations examined, but predicted the experimentally observed MSC/MIC ratio well (R<sup>2</sup> &#x2265; 0.95). The shape of the antibiotic response curve varied among compounds (0.7 &#x2264; &#x03BA; &#x2264; 10.5), with the steepest curve for the aminoglycosides streptomycin and kanamycin. The model was sensitive to this antibiotic response curve shape and to the sc, indicating the importance of fitness differences between strains for determining the MSC. The MSC can be more than one order of magnitude lower than the MIC, typically by a factor sc<sup>&#x03BA;</sup>. This study provides an initial quantitative depiction and a framework for a research agenda to examine the growing evidence of selection for resistant bacteria communities at low environmental antibiotic concentrations.</p>
</abstract>
<counts>
<page-count count="38"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Effective management of antibiotic risks in the environment requires an understanding of the factors responsible for the emergence, transmission, and maintenance of antibiotic resistance (<xref rid="c1" ref-type="bibr">1</xref>). It is particularly important to address the question of when resistant bacteria predominate as a result of environmental antibiotic pollution (<xref rid="c1" ref-type="bibr">1</xref>&#x2013;<xref rid="c5" ref-type="bibr">5</xref>). For example, insights are also needed into the extent to which antibiotics in aquatic environments contribute to the spread of resistance, and to the long-term prevalence of resistant infections in humans (<xref rid="c2" ref-type="bibr">2</xref>, <xref rid="c5" ref-type="bibr">5</xref>).</p>
<p>The mutant selection window (MSW) paradigm states that resistant mutants may develop between the lowest boundary concentration of selection for resistance, and the upper boundary concentration of growth inhibition of the most resistant potential mutant (the mutant prevention concentration, MPC) (<xref rid="c6" ref-type="bibr">6</xref>, <xref rid="c7" ref-type="bibr">7</xref>). The paradigm further indicates that the lower boundary concentration of the MSW is the minimum concentration that inhibits colony formation (MIC, ng ml<sup>-1</sup>), and the MIC has been useful to evaluate hazard of selection for resistance in natural aquatic environments (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c8" ref-type="bibr">8</xref>). Considerable research <italic>in vitro</italic> and <italic>in vivo</italic> has demonstrated that resistant mutants develop between the MIC and the MPC (<xref rid="c7" ref-type="bibr">7</xref>, <xref rid="c9" ref-type="bibr">9</xref>, <xref rid="c10" ref-type="bibr">10</xref>), but many laboratory and theoretical studies indicate that resistant mutants can also be preferentially selected above the minimum selective concentration (MSC, ng ml<sup>-1</sup>), defined as the lowest concentration at which a resistant strain outcompetes and displaces sensitive isolates (<xref rid="c1" ref-type="bibr">1</xref>, <xref rid="c11" ref-type="bibr">11</xref>&#x2013;<xref rid="c18" ref-type="bibr">18</xref>). Because the MSC can be lower than the MIC, and to minimize the hazard of resistance occurring in the natural environment (e.g., aquatic systems), further characterization and understanding of the MIC versus MSC relationship would be beneficial (<xref rid="c8" ref-type="bibr">8</xref>).</p>
<p>Laboratory experiments (<xref rid="c11" ref-type="bibr">11</xref>&#x2013;<xref rid="c13" ref-type="bibr">13</xref>, <xref rid="c16" ref-type="bibr">16</xref>, <xref rid="c18" ref-type="bibr">18</xref>) have elegantly demonstrated MSCs ranging from 1/4 to below 1/200 of the MIC for antibiotics of several classes (e.g., macrolide, aminoglycoside, fluoroquinolone, and antifolate) and for two metals in <italic>Escherichia coli</italic> (<italic>E. coli</italic>) or <italic>Salmonella enterica</italic> serovar Typhimurium LT2 (<italic>S.</italic> Typhimurium). This finding may help explain the high levels of resistance found in the environment, particularly at subinhibitory antibiotic concentrations (<xref rid="c2" ref-type="bibr">2</xref>, <xref rid="c5" ref-type="bibr">5</xref>, <xref rid="c11" ref-type="bibr">11</xref>). These studies further indicate that the fitness cost of the resistance-conferring mutations is more important than differences in MIC between strains for discerning how much below the MIC the resistant bacteria will predominate (<xref rid="c12" ref-type="bibr">12</xref>). However, a mathematical description of the competition between strains would aid in understanding strain- and antibiotic-specific results and generalizing to a wider range of situations.</p>
<p>Mechanistic mathematical models, including experimentally validated pharmacodynamic/ pharmacokinetic models, describe antibiotic effects better than simple MIC measurements (<xref rid="c19" ref-type="bibr">19</xref>&#x2013;<xref rid="c23" ref-type="bibr">23</xref>). For example, the shape of the antibiotic dose&#x2013;response curve is very important to the microbiological efficacy of antibiotic treatment regimens at high (treatment) levels (<xref rid="c19" ref-type="bibr">19</xref>). The implications of this understanding of dose&#x2013;response curve shape for low (subinhibitory) antibiotic levels and for calculation of the MSC, while relevant for selection of resistance, have not been considered in as much depth. To complement the recent empirical research (<xref rid="c1" ref-type="bibr">1</xref>, <xref rid="c11" ref-type="bibr">11</xref>&#x2013;<xref rid="c13" ref-type="bibr">13</xref>, <xref rid="c16" ref-type="bibr">16</xref>, <xref rid="c18" ref-type="bibr">18</xref>), there remains a need for a quantitative model describing the MSC, i.e., the minimum environmental antibiotic concentration that allows resistant bacterial strains to dominate. Such a model can generate testable predictions, identify the factors that determine water or soil antibiotic concentrations that select for resistance, and be incorporated into risk assessments of antibiotic resistance development (<xref rid="c1" ref-type="bibr">1</xref>).</p>
<p>An analytical solution for the MSC has two potential uses. First, model sensitivity analysis and examination of parameter structure may provide insight on the relationship between commonly considered bacterial growth and antibiotic dose&#x2013;response parameters and the MSC itself. Second, current methodology to accurately measure the MSC requires direct measurement of competition between bacterial strains and specialized methods such as fluorescent cell tagging and flow cytometry (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). An analytical solution provides a potential alternative to these methods, instead estimating the MSC based on bacterial growth rate and antibiotic dose&#x2013;response parameters that are routinely obtained within microbiology laboratories. To that end this paper addresses three questions: 1. How do we quantitatively define the minimum selective concentration (MSC) via a parsimonious mathematical model in combination with readily available measurements? 2. How well does such a mathematical model of MSC fit to published empirical data? 3. What model parameters, representing biological characteristics, are most important to describe the MSC?</p>
<p>The model we propose in this paper describes the MSC based on the competition between a wild-type and a resistant strain of bacteria, and the key factors that favor the growth of resistant strains at subinhibitory antibiotic concentrations. The model focuses on conspecific gram negative bacteria (GNB), and is calibrated to the experimental results of Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>) for <italic>E. coli</italic> and <italic>S.</italic> Typhimurium. The model illustrates the shape of the antibiotic dose&#x2013;response curve as a measurable and influential driver on the ratio of the MSC and MIC, and presents a hypothesized dose&#x2013;response relationship for use in risk assessment of resistance development in environmental settings. Finally, we discuss the implications of the MSC results for increased risk of antibiotic resistance selection at antibiotic concentrations observed in antibiotic-contaminated waste streams and natural waters.</p>
</sec>
<sec id="s2">
<title>Theory</title>
<p>We develop a simple analytical expression of the ratio between the MSC and the MIC for a sensitive strain (i.e., MSC/MIC), which mathematically describes the factors that determine risks of subclinical antibiotic concentrations (<xref rid="c11" ref-type="bibr">11</xref>, <xref rid="c12" ref-type="bibr">12</xref>). The model is based on the competition between two bacterial strains: a wild type sensitive strain, and mutant strain that is more resistant.</p>
<sec id="s2a">
<title>Model derivation for net growth rate</title>
<p>At a given antibiotic concentration <italic>a</italic> [ng ml<sup>-1</sup>], the net growth rate (N(<italic>a</italic>), [h<sup>-1</sup>]) for each strain is given by
<disp-formula id="eqn1">
<alternatives>
<graphic xlink:href="176289_eqn1.gif"/>
</alternatives>
</disp-formula>
<disp-formula id="eqn2">
<alternatives>
<graphic xlink:href="176289_eqn2.gif"/>
</alternatives>
</disp-formula>
where subscript s = sensitive bacteria, subscript r = resistant bacteria, N<sub>int,s</sub> = (R<sub>int</sub> &#x2013; D<sub>int</sub>) = intrinsic net growth rate in the absence of antibiotic [h<sup>-1</sup>],, calculated as the difference between the intrinsic growth rate (Rint =[ h<sup>-1</sup>]) and the intrinsic loss due to mortality (or, in continuous cultures, dilution) (Dint, [h<sup>-1</sup>]), D<sub>ab</sub>(<italic>a</italic>) = loss in net growth [h<sup>-1</sup>] due to a given antibiotic concentration, <italic>a</italic>, and &#x03C3; = absolute selection coefficient [h<sup>-1</sup>].</p>
<p>The absolute selection coefficient (&#x03C3;) represents the loss in fitness of resistance-conferring genes as the absolute difference in net growth rate between bacteria strains (e.g., sensitive vs. resistant) in the absence of antibiotics (i.e., N<sub>int,r</sub> = N<sub>int,s</sub> &#x002B; &#x03C3;). The absolute selection coefficient (&#x03C3;) is directly related to the fitness cost (see supplemental material about the exact definition of fitness cost and its relation to the absolute selection coefficient). Accurate measurement of the absolute selection coefficient (&#x03C3;) can be difficult, employing competition experiments with labeled strains and flow cytometry (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>, <xref rid="c24" ref-type="bibr">24</xref>). Resistance-conferring mutations exhibit highly variable selection coefficients in comparison to sensitive strains (<xref rid="c24" ref-type="bibr">24</xref>&#x2013;<xref rid="c27" ref-type="bibr">27</xref>), with compensatory mutations often reducing or reversing the fitness cost of resistance mechanisms (<xref rid="c26" ref-type="bibr">26</xref>, <xref rid="c28" ref-type="bibr">28</xref>, <xref rid="c29" ref-type="bibr">29</xref>). For the purposes of this model, we run simulations on the assumption that resistance-conferring mutations engender a loss in fitness, resulting in lower growth rates relative to less resistant strains, i.e., &#x03C3; &#x003C; 0 in <xref ref-type="disp-formula" rid="eqn2">Eq. 2</xref>. This assumption is supported in that the majority of single mutational events entail a loss in fitness (<xref rid="c24" ref-type="bibr">24</xref>).</p>
<p>The loss in net growth due to antibiotics can be described by a generalized Hill Equation (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c21" ref-type="bibr">21</xref>, <xref rid="c30" ref-type="bibr">30</xref>&#x2013;<xref rid="c32" ref-type="bibr">32</xref>):
<disp-formula id="eqn3">
<alternatives>
<graphic xlink:href="176289_eqn3.gif"/>
</alternatives>
</disp-formula>
in which k<sub>max</sub> [h<sup>-1</sup>] is the maximum death rate due to antibiotic, EC<sub>50</sub> [ng ml<sup>-1</sup>] is the antibiotic concentration that achieves half of this maximum rate, and will thus increase with increased resistance, and &#x03BA; is the Hill coefficient, which gives an indication of how steeply D<sub>ab</sub> increases near the MIC (<xref rid="c31" ref-type="bibr">31</xref>). For &#x03BA; = 1 in the range of antibiotic concentrations below the MIC, the death rate increases roughly linearly. For a given strain, antibiotics with a high &#x03BA; value (&#x003E; 1) will have lower efficacy at sub-therapeutic levels, but higher efficacy at therapeutic levels above the MIC. The opposite relation is true for antibiotics with low &#x03BA; values (<xref rid="c19" ref-type="bibr">19</xref>) as illustrated in <xref ref-type="fig" rid="fig1">Fig. 1A</xref>.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Fig. 1.</label>
<caption><p>Growth rate versus antibiotic concentration. (A) Single strain (MIC<sub>r</sub> = 40) with different kappa (&#x03BA;) values. (B, C) Sensitive and resistant strains (MIC<sub>s</sub> = 10, MIC<sub>r</sub> = 30, &#x03BA; = 2). (C) enlarged view around the MSC (&#x2022;), the concentration where growth curves cross (&#x0394;N = 0). Other parameter values: selection coefficient = 0.05, N<sub>int,s</sub> = 2, N<sub>min</sub> = &#x2212;5.</p></caption>
<graphic xlink:href="176289_fig1.tif"/>
</fig>
<p>To determine k<sub>max</sub> from growth and death rates, we note that k<sub>max</sub> should correspond to the difference between the maximum possible net growth rate (not limited by resource availability or antibiotics; i.e., N<sub>int</sub>), and the minimum possible growth rate, after accounting for the growth limiting activity of antibiotic (N<sub>min</sub>):
<disp-formula id="eqn4">
<alternatives>
<graphic xlink:href="176289_eqn4.gif"/>
</alternatives>
</disp-formula></p>
<p>Generally, N<sub>min</sub> &#x003C; 0, indicating population decline at maximum antibiotic exposure level. The EC<sub>50</sub> can be directly related to the MIC value [ng ml<sup>-1</sup>]; as a result, the following formulation of D<sub>ab</sub> applies for our formalism (full derivation in the supplemental material):
<disp-formula id="eqn5">
<alternatives>
<graphic xlink:href="176289_eqn5.gif"/>
</alternatives>
</disp-formula>
<disp-formula id="eqn6">
<alternatives>
<graphic xlink:href="176289_eqn6.gif"/>
</alternatives>
</disp-formula></p>
<p>Equations 5 and 6 assume identical &#x03BA; and N<sub>min</sub> for sensitive versus resistant strains, which may not be accurate. Later in the text, we revisit the impact of this assumption for estimation of the MSC.</p>
</sec>
<sec id="s2b">
<title>Difference in net growth rate and derivation of MSC as function of MIC</title>
<p>Competition between different bacterial strains is expressed by the difference in net growth rates. According to the conceptual model described by Andersson and Hughes (<xref rid="c11" ref-type="bibr">11</xref>) and Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>), N<sub>s</sub> &#x003E; N<sub>r</sub> at low antibiotic concentrations, but the greater sensitivity causes more antibiotic-dependent growth inhibition for the sensitive strain. As a result, at high antibiotic concentrations, N<sub>r</sub> &#x003E; N<sub>s</sub>, and the MSC is the point of intersection of the two growth curves (N<sub>s</sub> = N<sub>r</sub>) for which the difference in net growth rate is zero (<xref ref-type="fig" rid="fig1">Fig. 1B-C</xref>).</p>
<p>Analytically, this difference in net growth rates between the resistant and the sensitive strain (&#x0394;N(a) [h<sup>-1</sup>]) is determined by subtracting <xref ref-type="disp-formula" rid="eqn1">Eq. 1</xref> from <xref ref-type="disp-formula" rid="eqn2">Eq. 2</xref>, giving:
<disp-formula id="eqn7">
<alternatives>
<graphic xlink:href="176289_eqn7.gif"/>
</alternatives>
</disp-formula></p>
<p>Thus, the MSC is the antibiotic concentration (i.e., a = MSC) at which the two net growth rates are equal and the difference (<xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref>) is zero:
<disp-formula id="eqn8">
<alternatives>
<graphic xlink:href="176289_eqn8.gif"/>
</alternatives>
</disp-formula></p>
<p>This is the concentration at which the additional loss in net growth due to antibiotic in the sensitive strain compared to the resistant (D<sub>ab,s</sub>(MSC) - D<sub>ab,r</sub>(MSC)) compensates for the effect of fitness loss (&#x03C3;).</p>
<p>To derive the ratio of MSC/MIC we employ a dimensionless relative selection coefficient (sc [unitless]), obtained by reversing the sign of the reported absolute selection coefficient (&#x03C3;) (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>), and then dividing by the net growth rate of the sensitive strain (full derivation in the supplemental material):
<disp-formula id="eqn9">
<alternatives>
<graphic xlink:href="176289_eqn9.gif"/>
</alternatives>
</disp-formula></p>
<p>Based on the above equations, and further assuming that &#x03BA; and N<sub>min</sub> are the same for sensitive and resistant strains, the following analytical solution for MSC/MIC<sub>s</sub> is obtained (full derivation in the supplemental material):
<disp-formula id="eqn10">
<alternatives>
<graphic xlink:href="176289_eqn10.gif"/>
</alternatives>
</disp-formula></p>
<p>In the case of a large difference in resistant versus sensitive MIC, the right-hand term in the denominator approaches zero, and the equation simplifies to:
<disp-formula id="eqn11">
<alternatives>
<graphic xlink:href="176289_eqn11.gif"/>
</alternatives>
</disp-formula></p>
<p>This simplification does not apply to small increases in MIC, such as the <italic>&#x0394;marR</italic> and <italic>&#x0394;acrR</italic> mutants which double the MIC for ciprofloxacin (<xref rid="c12" ref-type="bibr">12</xref>). <xref ref-type="disp-formula" rid="eqn11">Eq. 11</xref> becomes appropriate once MIC<sub>r</sub> &#x003E; 5 x MIC<sub>s</sub>, at which point results from Eqs. 10 and 11 become approximately equal (supplemental material Fig. S1).</p>
<p><xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> is, in essence, a mathematical hypothesis regarding the relationship between the antibiotic dose&#x2013;response and the resulting MSC. The form of <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> aids in determining which aspects of the growth rate are likely to be most important for competition at low antibiotic doses. Eqs. 10 and 11 also represent a potential alternative to direct measurement of MSC. &#x03BA;, N<sub>int,s</sub>, and N<sub>min</sub> could be measured in the laboratory (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c33" ref-type="bibr">33</xref> provide examples) and other parameters obtained from literature. <xref ref-type="disp-formula" rid="eqn4">Eq. 4</xref> would be fit to experimental measures of the sensitive strain&#x2019;s antibiotic versus growth dose&#x2013;response to obtain &#x03BA; and k<sub>max</sub>, and N<sub>min</sub> would then be based on the strain intrinsic growth rate (N<sub>int</sub>) minus k<sub>max</sub> (<xref ref-type="disp-formula" rid="eqn5">Eq. 5</xref>).</p>
<p>As mentioned above, <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> rests on the assumption of identical &#x03BA; and N<sub>min</sub> for sensitive versus resistant strains. An analytical solution analogous to <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> could not be obtained assuming separate &#x03BA; and N<sub>min</sub> (i.e., &#x03BA;s, &#x03BA;r, N<sub>min,s</sub>, N<sub>min,r</sub>). In the Results section below and supplemental material, we employ a Monte Carlo Simulation sensitivity analysis to critically evaluate this assumption of identical &#x03BA; and N<sub>min</sub>.</p>
</sec>
<sec id="s2c">
<title>Model evaluation against experimental results</title>
<p>The analytical solution was evaluated by comparison to the experimental results of Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). This evaluation was performed to determine whether the model fit to actual competition data was reasonable, and to identify representative parameter sets for N<sub>min</sub> and &#x03BA;, parameters, given a set of published values of MIC<sub>s</sub>, MIC<sub>r</sub>, &#x03C3; and N<sub>int,s</sub> <sub>(<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>)</sub>. The latter four parameters have been characterized for a wide range of strains, conditions, and resistance mechanisms (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c25" ref-type="bibr">25</xref>, <xref rid="c26" ref-type="bibr">26</xref>, <xref rid="c28" ref-type="bibr">28</xref>, <xref rid="c34" ref-type="bibr">34</xref>&#x2013;<xref rid="c36" ref-type="bibr">36</xref>).</p>
<p>Model fitting was achieved by fitting &#x0394;N values calculated from <xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref> (based on Eqs. 1, 2, and 4 - 6) to the &#x0394;N values observed in Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). The function NonLinearModel.fit in MATLAB (Statistics Toolbox, R2013a, MathWorks, Natick, MA, USA) was used to estimate N<sub>min</sub> and &#x03BA;. Fitting was performed separately for seven individual antibiotic-bacteria combinations across the published range of experimental concentrations, as well as for arsenite- and copper-exposed <italic>E. coli</italic> (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). These metals were included based on co-resistance and cross-resistance with antibiotics, as well as similar mechanisms of genetic transmission among bacteria (<xref rid="c2" ref-type="bibr">2</xref>, <xref rid="c5" ref-type="bibr">5</xref>, <xref rid="c37" ref-type="bibr">37</xref>, <xref rid="c38" ref-type="bibr">38</xref>). For each compound, resistance was compared between a sensitive (wild-type) strain and one to four resistant strains in <italic>S.</italic> Typhimurium or <italic>E. coli</italic>. From the published experiments (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>), only the chromosomal mechanism of trimethoprim resistance was excluded because it exhibited an average selection coefficient &#x03C3; &#x003E; 0, indicating no selective disadvantage of resistance (<xref rid="c12" ref-type="bibr">12</xref>).</p>
<p>To evaluate <xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref> and the underlying model assumptions, model-predicted vs. observed &#x0394;N were compared. To evaluate robustness to individual observations, cross-validation (CV) was also employed. For CV, the optimization was performed with each single data point removed in series, and the average and range of N<sub>min</sub> and &#x03BA; results were examined, as well as the calculated vs. observed &#x0394;N for the out-of-sample observations. The PRESS statistic (predictive residual sum of squares) was calculated, and PRESS/SSY and PRESS/SSE were examined to indicate model prediction error and robustness to individual observations, respectively (<xref rid="c39" ref-type="bibr">39</xref>). All analyses were performed on the experimental average results for each strain and antibiotic concentration examined, reported by Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). Analyses were also performed on the raw data for each experimental observation (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref> supplemental material), in order to consider the impact of experimental variation on results.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<p><xref ref-type="fig" rid="fig1">Figure 1</xref> depicts the change in growth rate versus antibiotic concentration (<xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref>), the crossover point between growth rate of sensitive and resistant strains (i.e., the MSC, <xref ref-type="disp-formula" rid="eqn8">Eq. 8</xref>), and an analytical solution for the MSC/MIC ratio (Eqs. 10, 11). The MSC can be observed as the antibiotic concentration at which N<sub>s</sub> (<xref ref-type="disp-formula" rid="eqn1">Eq. 1</xref>) and N<sub>r</sub> (<xref ref-type="disp-formula" rid="eqn2">Eq. 2</xref>) cross, indicating identical growth of sensitive and resistant strains (<xref ref-type="fig" rid="fig1">Fig. 1B-C</xref>, <xref ref-type="disp-formula" rid="eqn8">Eq. 8</xref>). The MSC/MIC ratio (<xref rid="c12" ref-type="bibr">12</xref>) is of interest because it indicates how much lower the MSC is relative to the MIC; this enables estimation of the environmental antibiotic concentration at which resistance selection could occur among competing bacteria populations (<xref rid="c1" ref-type="bibr">1</xref>, <xref rid="c15" ref-type="bibr">15</xref>). The MSC can be estimated employing this ratio, in combination with routinely available MIC data (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c8" ref-type="bibr">8</xref>, <xref rid="c34" ref-type="bibr">34</xref>, and the EUCAST database: <ext-link ext-link-type="uri" xlink:href="http://www.srga.org/eucastwt/wt_eucast.htm">http://www.srga.org/eucastwt/wt_eucast.htm</ext-link>).</p>
<p>We first evaluate the model by examining a key assumption and then comparing predicted growth rates and MSC/MIC ratios to published data. We then examine model behavior and implications for MSC/MIC ratio prediction. Finally, we perform a sensitivity analysis to identify the most important parameters for predicting this ratio.</p>
<sec id="s3a">
<title>Model evaluation</title>
<sec id="s3a1">
<title>Effect of varying &#x03BA; and N<sub>min</sub> for sensitive versus resistant strains:</title>
<p>The analytical solution for <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> requires identical &#x03BA; and N<sub>min</sub> for sensitive versus resistant strains. We evaluated the impact of this assumption on model predictions by determining which strain-specific parameter values (i.e., &#x03BA;s, &#x03BA;r, N<sub>min,s</sub>, or N<sub>min,r</sub>) were most important for predicting MSC. To achieve this, we performed a Monte Carlo Simulation sensitivity analysis, detailed in the text and Table S1 (supplemental material). In two simulations, the predicted value of MSC was obtained in <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref>, assuming separate &#x03BA;s, &#x03BA;r, N<sub>min,s</sub>, and N<sub>min,r</sub> in Eqs. 5 and 6. To be robust to MIC ratio variations, the first simulation had MIC<sub>r</sub> = 1.5 x MIC<sub>s</sub> whereas the second had MIC<sub>r</sub> = 10 x MIC<sub>s</sub>. In both simulations, MSC was highly sensitive to &#x03BA;s, (Spearman rank correlation coefficient, &#x03C1; &#x003E; 0.8) but was insensitive to N<sub>min,</sub> <sub>s</sub> or N<sub>min,</sub> <sub>r</sub> (&#x007C;Spearman &#x03C1;&#x007C; &#x2264; 0.11). This much stronger influence of &#x03BA; than N<sub>min</sub> is expected based on the fact that &#x03BA; is an exponential term (Eqs. 10, 11). MSC was also more sensitive to &#x03BA;s than &#x03BA;r, and &#x007C;Spearman &#x03C1;&#x007C; between &#x03BA;s and MSC (&#x03C1; = 0.83) was more than twice &#x007C;&#x03C1;&#x007C; between &#x03BA;r and MSC (&#x03C1; = &#x2212;0.39). When MIC<sub>r</sub> = 10 x MIC<sub>s</sub>, almost all variation in MSC was explained by &#x03BA;s (&#x03C1; = 0.97), with &#x03C1; = &#x2212;0.09 for &#x03BA;r. These results indicate that MSC will strongly depend on &#x03BA;s, the shape of the antibiotic dose&#x2013;response for the sensitive strain. As a result, for indirect estimation of MSC using <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref>, &#x03BA;s should be well characterized experimentally.</p>
</sec>
<sec id="s3a2">
<title>Model performance for predicting difference in net growth rates:</title>
<p><xref ref-type="fig" rid="fig2">Figs. 2</xref> and <xref ref-type="fig" rid="fig3">3</xref> display the difference in net growth rates for sensitive versus resistant strains (&#x0394;N) for previously published experimental data in comparison to the model (<xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref>). <xref ref-type="fig" rid="fig2">Fig. 2</xref> illustrates how &#x0394;N increases with increasing antibiotic concentration for the ciprofloxacin experiments in Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>), with variability due to examination of four bacterial strains. <xref ref-type="fig" rid="fig3">Fig. 3</xref> directly compares the experimentally observed versus model predicted &#x0394;N for all antibiotics and metals examined. The model predicted results overlapped with the range of experimental observations for most conditions. Much of the variability was attributable to experimental variation rather than model error, as evident in the horizontal spread of points for each compound. However, the model underpredicted experimental results for the aminoglycosides, KAN and STR (open circles in <xref ref-type="fig" rid="fig3">Fig. 3</xref>) when &#x0394;N was &#x003C; 0.05. Consequently, linear regression indicated &#x0394;N<sub>modeled</sub> = 0.93(&#x0394;N<sub>observed</sub>) &#x2013; 0.002, a slight underprediction. Examining results for individual compounds, model performance (R<sup>2</sup>, Q<sup>2</sup>, and PRESS/SSY) was generally similar when either one parameter (&#x03BA;) or two parameters (&#x03BA;, N<sub>min</sub>) were fitted, and for either the raw or averaged experimental data (supplemental material Table S2). For CIP, ERY, KAN, and STR, the model fit was insensitive to N<sub>min</sub>, exhibiting a wide range of possible values, and a limited impact on model fit. Therefore, N<sub>min</sub> was fixed at a representative literature value of N<sub>min</sub> = &#x2212;2 (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c33" ref-type="bibr">33</xref>, <xref rid="c40" ref-type="bibr">40</xref>), and &#x03BA; was fitted to experimental observations. The fitted model was generally consistent with raw observations (R<sup>2</sup> &#x003E; 0.8) and the model exhibited high predictive value in cross validation (Q<sup>2</sup> &#x003E; 0.8) for TET, TMP, ERY, and As in <italic>E. coli</italic>, and for TET in Salmonella (<xref ref-type="table" rid="tbl1">Table 1</xref>, supplemental material Fig. S2). Model fit was moderate for CIP (R<sup>2</sup> = 0.78, <xref ref-type="fig" rid="fig2">Fig. 2</xref>), Cu (R<sup>2</sup> = 0.73), and STR (R<sup>2</sup> = 0.67). For KAN, the model fit was poor, worse than a simple average of the data, i.e., slope = 0 (R<sup>2</sup> &#x003C; 0), indicating that it was not possible to fit the model to the KAN data. Model fit to KAN was also poor for several alternative statistical models, including Weibull, logit, logistic, and probit formulations.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Fig. 2.</label>
<caption><p>Comparison between experimentally observed (<xref rid="c12" ref-type="bibr">12</xref>) and model predicted difference in net growth rate between sensitive and resistant bacterial strains (&#x0394;N, from <xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref>) as a function of ciprofloxacin concentration in <italic>E. coli</italic>.</p></caption>
<graphic xlink:href="176289_fig2.tif"/>
</fig>
<fig id="fig3" position="float" fig-type="figure">
<label>Fig. 3.</label>
<caption><p>Model predicted versus &#x0394;N observed for all experiments (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). Abbreviations: As = arsenite. Cu = copper. AG = aminoglycoside antibiotic. Ec = <italic>E. coli</italic>. St = <italic>S.</italic> Typhimurium.</p></caption>
<graphic xlink:href="176289_fig3.tif"/>
</fig>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><p>Results of model (<xref ref-type="disp-formula" rid="eqn7">Eq. 7</xref>) optimization to published (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>) empirical growth rate differences (&#x0394;N) between sensitive and resistant strains, based on strain-specific &#x03C3;, MIC<sub>s</sub>, and MIC<sub>r</sub>. &#x03BA; was fitted and raw experimental &#x0394;N data was employed. Other model parameters: N<sub>int,s</sub> = 1.8, N<sub>min</sub> = &#x2212;2 (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c33" ref-type="bibr">33</xref>, <xref rid="c40" ref-type="bibr">40</xref>). MSC/MIC<sub>s</sub> calculated using <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> with selection coefficients published for resistant strains (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>).</p></caption>
<graphic xlink:href="176289_tbl1.tif"/>
</table-wrap>
<p>As shown in <xref ref-type="table" rid="tbl1">Table 1</xref>, the fitted &#x03BA; ranged widely across the nine compounds examined (0.7 to 10.5). CV results generally produced a very narrow range, with &#x03BA; varying by &#x003C; 0.1 within individual compounds, except KAN and Cu (supplemental material Table S2). Similarly, CV PRESS/SSY results were &#x003C; 0.4 for all compounds except KAN and Cu. Values &#x003C; 0.4 are considered to indicate reasonably low model prediction error (<xref rid="c39" ref-type="bibr">39</xref>). The PRESS/SSE were below 1.15 for all compounds except Cu; these values of PRESS/SSE close to 1 indicate limited dependence of model prediction accuracy on individual observations.</p>
<p>Because it was the only experiment that included four resistance genotypes, ciprofloxacin was examined more closely. Overall, fit and predictive ability were generally reasonable (R<sup>2</sup> = 0.81, Q<sup>2</sup> = 0.78, PRESS/SSY = 0.29, supplemental material Table S2) except for downward bias in the two highest &#x0394;N results (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). These were both <italic>gyrA1</italic> [<italic>S83L</italic>] versus sensitive wild-type above 2 ng/ml ciprofloxacin (<xref rid="c19" ref-type="bibr">19</xref>). The <italic>gyrA1</italic> [<italic>S83L</italic>] comparison had a substantially different curve shape, and removing this strain from the data greatly improved the model fit (R<sup>2</sup> = 0.97, Q<sup>2</sup> = 0.97, PRESS/SSY = 0.04). However the change in predicted &#x03BA; was trivial (from 2.0 to 2.1, with N<sub>min</sub> fixed at &#x2212;2).</p>
</sec>
<sec id="s3a3">
<title>Minimum Selection Concentration:</title>
<p>MSC/MIC<sub>s</sub> was estimated (<xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref>) based on model fitted &#x03BA;, and empirical values for sc, MIC<sub>r</sub>, and MIC<sub>s</sub>. For these estimates, N<sub>int,s</sub> was set at 1.8 h<sup>-1</sup> and N<sub>min</sub> was either fitted or set at &#x2212;2 h<sup>-1</sup>. Model predictions corresponded well to the observed MSC/MIC<sub>s</sub> (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>) for all experiments, with either fixed or fitted N<sub>min</sub> (<xref ref-type="fig" rid="fig4">Fig. 4</xref>), suggesting that the model is appropriate to estimate the MSC/MIC<sub>s</sub> ratio. The MSC/MIC<sub>s</sub> ratio ranged across two orders of magnitude from 0.006 to 0.66 (<xref ref-type="table" rid="tbl1">Table 1</xref>, supplemental material Table S3).</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Fig. 4.</label>
<caption><p>Comparison of observed (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>) versus model predicted (<xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref>) MSC/MIC<sub>s</sub>. Symbols represent experimentally evaluated resistant strains (N = 14). Solid line (&#x2014;) is 1:1 ratio.</p></caption>
<graphic xlink:href="176289_fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="s3b">
<title>Sensitivity analysis</title>
<p>For a sensitivity analysis, behavior of <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> was examined across reasonable parameter ranges to examine sensitivity of MSC/MIC<sub>s</sub> to fitness differences (sc), antibiotic resistance differences (MIC<sub>r</sub>/MIC<sub>s</sub>), maximum growth rate inhibition (N<sub>min</sub>), and intrinsic growth rate (N<sub>int,s</sub>), respectively. Eqs. 10 and 11 indicate that MSC/MIC<sub>s</sub> is primarily a function of sc and &#x03BA;, but is also modified by corrective terms that include N<sub>min</sub>, N<sub>int,s</sub>, N<sub>int,r</sub>, MIC<sub>s</sub>, and MIC<sub>r</sub>. <xref ref-type="fig" rid="fig5">Fig. 5</xref> demonstrates the influences of sc and &#x03BA; on MSC/MIC<sub>s</sub>. Specifically, increasing sc lowers the resistant strain growth rate (<xref ref-type="fig" rid="fig5">Fig. 5A-B</xref>), whereas increasing &#x03BA; increases the curvature of the sensitive strain growth rate (<xref ref-type="fig" rid="fig5">Fig. 5B-D</xref>), both resulting in increased MSC/MIC<sub>s</sub>. As a result, modeled &#x03BA; is strongly associated with model predicted MSC/MIC<sub>s</sub>. Thus, the Pearson correlation coefficient was very high (r = 0.94) for the &#x03BA; versus MSC/MIC<sub>s</sub> results from <xref ref-type="table" rid="tbl1">Table 1</xref>.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Fig. 5.</label>
<caption><p>Growth rate versus antibiotic concentration for sensitive (N<sub>s</sub>) and resistant (N<sub>r</sub>) bacteria for different values of sc (0.01, 0.1) and &#x03BA; (<xref rid="c1" ref-type="bibr">1</xref>, <xref rid="c2" ref-type="bibr">2</xref>, <xref rid="c3" ref-type="bibr">3</xref>). Other parameters (all scenarios): MIC<sub>s</sub> = 10, MIC<sub>r</sub> = 40, N<sub>int,s</sub> = 2, N<sub>min</sub> = &#x2212;5.</p></caption>
<graphic xlink:href="176289_fig5.tif"/>
</fig>
<p><xref ref-type="fig" rid="fig6">Fig. 6</xref> provides plots of the MSC/MIC<sub>s</sub> ratio as the solution for <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> across different parameter values. <xref ref-type="fig" rid="fig6">Fig. 6A</xref> confirms the dominant and interdependent influences of sc and &#x03BA; on MSC/MIC<sub>s</sub> with the largest influences at or below &#x03BA; values of 1. At &#x03BA; = 1, MSC/MIC<sub>s</sub> &#x2248; sc (<xref ref-type="fig" rid="fig6">Fig. 6A</xref>, blue dashed line). The influences of sc and &#x03BA; can be combined according to Eqs. 10 and 11, which indicate that the MSC/MIC<sub>s</sub> ratio is proportional to sc<sup>1/</sup><sup>&#x03BA;</sup>. <xref ref-type="fig" rid="fig6">Figs. 6B-D</xref> illustrate that MSC/MIC<sub>s</sub> is proportional to sc<sup>1/</sup><sup>&#x03BA;</sup> and that the slope of this relationship is modified by MIC<sub>r</sub>, N<sub>int,s</sub>, and N<sub>min</sub>. An increase in MIC<sub>r</sub> will decrease MSC/MIC<sub>s</sub>, but this relationship is only sensitive when MIC<sub>r</sub> approaches MIC<sub>s</sub> (<xref ref-type="fig" rid="fig6">Fig. 6B</xref>, MIC<sub>r</sub>/MIC<sub>s</sub> close to 1). The generally low sensitivity of MSC/MIC<sub>s</sub> to the MIC values themselves corroborates the empirical finding of Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>). Increasing N<sub>int,s</sub> also decreases MSC/MIC<sub>s</sub> but this only exhibits a minor influence in the plausible parameter range (<xref ref-type="fig" rid="fig6">Fig. 6C</xref>). Finally, increasing N<sub>min</sub> also decreases MSC/MIC<sub>s</sub>, but this is only sensitive when N<sub>min</sub> approaches zero (<xref ref-type="fig" rid="fig6">Fig. 6D</xref>). N<sub>min</sub> indirectly affects MSC/MIC<sub>s</sub> by influencing the MIC versus EC<sub>50</sub> relationship (Eqs. S7 and S8 in supplemental material).</p>
<fig id="fig6" position="float" fig-type="figure">
<label>Fig. 6.</label>
<caption><p>Sensitivity analysis of MSC/MIC<sub>s</sub> ratio (<xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref>) to model parameters: (A) as a function of the selection coefficients (sc) for different &#x03BA; (log scale); and as a function of sc<sup>1/</sup>&#x03BA; for different values of (B) MIC<sub>s</sub>/ MIC<sub>r</sub>, (C) N<sub>int,s</sub>, and (D) N<sub>min</sub>. Other parameters, except as noted: MIC<sub>s</sub> = 25, MIC<sub>r</sub> = 250, N<sub>int,s</sub> = 2, N<sub>min</sub> = &#x2212;5. Note: panel A is log scale and panels B-D are linear scale.</p></caption>
<graphic xlink:href="176289_fig6.tif"/>
</fig>
<p><xref ref-type="fig" rid="fig6">Fig. 6A</xref> also illustrates the expected range of the MSC/MIC<sub>s</sub> ratio across combinations of sc and &#x03BA; (the most influential parameters). Over commonly observed sc ranges from 0.001 to 0.1 and &#x03BA; ranges from 0.5 to 5 (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c25" ref-type="bibr">25</xref>, <xref rid="c26" ref-type="bibr">26</xref>, <xref rid="c28" ref-type="bibr">28</xref>), MSC/MIC<sub>s</sub> ranged widely from 10<sup>-6</sup> to 0.5. With sc = 0.01, as &#x03BA; decreased from 2 to 0.5, the MSC/MIC<sub>s</sub> ratio decreased from typically a factor of 0.1 down to less than a factor of 10<sup>-4</sup>, indicating that MSC values are very sensitive around &#x03BA; = 1. Especially for low sc, slight decreases in &#x03BA; may correspond to steep declines in the MSC value (<xref ref-type="fig" rid="fig6">Fig. 6A</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>This study model is a simple mathematical approach to describe the factors that will drive the MSC, which is a relevant environmental threshold concentration for selection of resistant bacteria. This model helps us understand the significant issue of environmental resistance spread (<xref rid="c1" ref-type="bibr">1</xref>, <xref rid="c5" ref-type="bibr">5</xref>, <xref rid="c41" ref-type="bibr">41</xref>) by mathematically formulating the dependence of the MSC (<xref rid="c11" ref-type="bibr">11</xref>, <xref rid="c15" ref-type="bibr">15</xref>) on the intrinsic growth rate and antibiotic versus growth dose-response. The model would enable indirect estimation of the MSC using measurements of bacterial growth parameters that are readily obtained in the laboratory and literature (&#x03BA;, N<sub>min</sub>, and N<sub>int</sub>), as an alternative and possible complement to direct measurement (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c13" ref-type="bibr">13</xref>, <xref rid="c16" ref-type="bibr">16</xref>). More importantly, the model identifies the shape of the antibiotic dose&#x2013;response curve of the sensitive strain (i.e., &#x03BA;) and the selection coefficient (sc) as the main parameters determining the MSC/MIC ratio. These traits, combined with literature MIC ranges (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c8" ref-type="bibr">8</xref>, <xref rid="c34" ref-type="bibr">34</xref>), can be used to estimate environmental antibiotic concentrations at which resistance could spread.</p>
<p>The model consistently estimated the MSC/MIC ratio across the nine compound and taxa combinations examined, with overall R<sup>2</sup> above 0.95 (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). This finding suggests that one could estimate the MSC given: 1. the MIC; 2. intrinsic bacterial growth rate (i.e., N<sub>int</sub>); 3. fitness loss (either &#x03C3; or sc measurements); and 4. the shape of a dose&#x2013;response curve for antibiotic concentration versus bacterial growth (i.e., &#x03BA;). The first three values are readily available for a range of strains, resistance mechanisms, and conditions (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c25" ref-type="bibr">25</xref>, <xref rid="c26" ref-type="bibr">26</xref>, <xref rid="c33" ref-type="bibr">33</xref>&#x2013;<xref rid="c36" ref-type="bibr">36</xref>). The antibiotic dose&#x2013;response curve varies across treatment conditions but is routinely obtained, allowing experimental calculation of &#x03BA; (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c21" ref-type="bibr">21</xref>, <xref rid="c32" ref-type="bibr">32</xref>, <xref rid="c33" ref-type="bibr">33</xref> provide examples).</p>
<p>To illustrate use of the model, <xref ref-type="fig" rid="fig7">Fig. 7</xref> displays the MSC/MIC ratio from <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> across a range of selection coefficients, based on laboratory growth parameters from Regoes et al. (<xref rid="c19" ref-type="bibr">19</xref>) and Ankomah et al. (<xref rid="c33" ref-type="bibr">33</xref>). Results vary dramatically across experiments, even for the same species-antibiotic combination (<xref ref-type="fig" rid="fig7">Fig. 7</xref>), largely due to variations in &#x03BA;. This suggests a strong impact of specific strains and growth conditions for selection, resulting in multiple orders of magnitude differences among systems, and a need to understand how the antibiotic resistance dose&#x2013;response varies across antibiotic-contaminated environments (<xref rid="c1" ref-type="bibr">1</xref>), including water treatment systems, agricultural waste pens, and natural waters and sediments (<xref rid="c4" ref-type="bibr">4</xref>, <xref rid="c42" ref-type="bibr">42</xref>&#x2013;<xref rid="c45" ref-type="bibr">45</xref>).</p>
<fig id="fig7" position="float" fig-type="figure">
<label>Fig. 7.</label>
<caption><p>MSC/MIC as a function of the selection coefficient sc, calculated for parameters obtained in laboratory empirical studies (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c33" ref-type="bibr">33</xref>). Parameter data in supplemental material Table S4.</p></caption>
<graphic xlink:href="176289_fig7.tif"/>
</fig>
<p>Though the model predicted the MSC/MIC well across the compounds examined, the model inconsistently predicted &#x0394;N among compounds. &#x0394;N was predicted least well for KAN and STR, both aminoglycosides. In these cases, the inability to fit &#x0394;N well was due to the similarity of the study-observed MSC versus the sensitive strain MIC (i.e., high MSC/MIC<sub>s</sub> ratio). This amounted to a sudden and dramatic shift from the low experimentally determined &#x0394;N values (&#x007C;&#x0394;N&#x007C; &#x003C; 0.04) around the MSC versus &#x0394;N &#x003E; 1 at the MIC. This steep dose&#x2013;response from high to zero growth of the sensitive strain is evident in high &#x03BA; values for both STR (&#x03BA; = 5) and KAN (&#x03BA; = 10.5). The Hill equation and other common statistical curves could not account for the similar MSC and MIC. The high &#x03BA; fitted is also inconsistent with the concentration-dependent (i.e., low &#x03BA;) bactericidal activity of aminoglycoside antibiotics described elsewhere (<xref rid="c32" ref-type="bibr">32</xref>, <xref rid="c46" ref-type="bibr">46</xref>). Instead, the similar net growth rates of susceptible versus resistant strains close to the MIC<sub>s</sub> may result from adaptive resistance of the susceptible strain. Adaptive resistance for aminoglycosides has been widely observed in <italic>Pseudomonas aeruginosa</italic> (<xref rid="c47" ref-type="bibr">47</xref>, <xref rid="c48" ref-type="bibr">48</xref>), including at sub-MIC exposures (<xref rid="c49" ref-type="bibr">49</xref>), as well as in <italic>E. coli (<xref rid="c22" ref-type="bibr">22</xref>, <xref rid="c40" ref-type="bibr">40</xref>, <xref rid="c50" ref-type="bibr">50</xref>)</italic>. This temporary development of phenotypic tolerance occurs due to elevated production of efflux pumps counteracting growth inhibition and killing at sublethal concentrations (<xref rid="c49" ref-type="bibr">49</xref>). In cases of adaptive resistance, the MSC may not be much lower than the MIC. In such cases, the MIC may be a reasonable proxy for the MSC, as is often observed clinically (<xref rid="c7" ref-type="bibr">7</xref>).</p>
<p>Experimental data are currently limited to a few species, strains, and antibiotics, possibly limiting the generalizability of the model performance evaluation. Thus, future experimental work is warranted to evaluate the ability to estimate MSC via Eqs. 10 and 11 across a range of subclinical conditions, species, strains, and antibiotics. This would include a comparison of MSC directly measured in competition experiments versus MSC derived from <xref ref-type="disp-formula" rid="eqn10">Eq. 10</xref> based on measurement of the antibiotic dose&#x2013;response of individual strains in isolation (Eqs. 4 and 5).</p>
<sec id="s4a">
<title>The shape of the antibiotic dose&#x2013;response at subinhibitory concentrations</title>
<p>By emphasizing subinhibitory antibiotic concentrations, this study extends prior findings regarding how the behavior of the Hill equation, and &#x03BA; in particular, influences the dynamics of bacterial net growth (<xref rid="c19" ref-type="bibr">19</xref>, <xref rid="c32" ref-type="bibr">32</xref>). The model predicts that an antibiotic with a lower &#x03BA; for a given set of conditions (e.g., bacterial strain, media) exerts a greater selective pressure in the subinhibitory region of concentrations found in the environment, resulting in lower MSC/MIC ratios. With &#x03BA; &#x2248; 1, there is an approximately linear decrease in growth from the intrinsic rate with no antibiotic to zero growth when the antibiotic concentration is equal to the MIC. As a result, the intersection between the curves for the wild-type versus resistant strain can occur at a low antibiotic concentration, and the MSC is approximately equal to the MIC of the wild-type multiplied by the selection coefficient. This leads to a low MSC for low selection coefficients.</p>
<p>For higher &#x03BA; conditions, the MSC is closer to the MIC. Thus, high &#x03BA;, in addition to increasing efficacy above the MIC (<xref rid="c19" ref-type="bibr">19</xref>), also reduces the hazard of selection for resistance at concentrations below the MIC. Simulated and empirical dose&#x2013;response measurements in the subinhibitory region are especially needed to evaluate the extent to which that &#x2018;pre-selection&#x2019; of resistant strains may occur at MSC levels below the MIC of the sensitive strain, in both clinical and environmental settings.</p>
</sec>
<sec id="s4b">
<title>Implications for resistance development hazard</title>
<p>Environmental-hazard and -risk assessments would benefit from determining how ambient environmental concentrations in different media compare to the MSC (<xref rid="c1" ref-type="bibr">1</xref>). Based on a species sensitivity distribution compared to EUCAST-published MIC results, Tello et al. found that selective pressure for resistant bacterial communities would be high in swine feces lagoon sediment but low in surface water, ground water, raw sewage, and sewage treatment plant effluent (<xref rid="c4" ref-type="bibr">4</xref>). As an example of the implications of the MSC threshold (versus the MIC), we reinterpret the model of Tello et al. (<xref rid="c4" ref-type="bibr">4</xref>) to estimate hazard of selection for resistant bacteria. We employ a model correction factor, assuming a 100-fold lower species sensitivity distribution, to convert the study reported MIC<sub>50</sub> (<xref ref-type="fig" rid="fig4">Fig. 4</xref> in Ref. 4) to an MSC<sub>50</sub> by adjusting the reported log-logistic model location (&#x03B1;) parameter by &#x2212;2. The 100-fold reduction follows our model results and the empirical data of Gullberg et al. (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>), both of which indicate MSC/MIC ratios may exhibit values below 0.01. Comparing the adjusted model to the field data reported for ciprofloxacin (Table 2 in Ref. 4), the MSC<sub>50</sub> model predicted a greater than 25&#x0025; potentially affected fraction of bacterial taxa in at least one sample for all media reported (surface water, river sediment, raw sewage, and treatment plant effluent). For erythromycin and tetracycline, the MSC<sub>50</sub> model predicted 65&#x0025; and 88&#x0025; potentially affected fraction in river sediment (vs. 2&#x0025; and 1.6&#x0025; for the MIC<sub>50</sub>) (<xref rid="c4" ref-type="bibr">4</xref>). Tello et al. used data from systems impacted by human and agricultural development (<xref rid="c42" ref-type="bibr">42</xref>, <xref rid="c43" ref-type="bibr">43</xref>), and our 100-fold MSC:MIC correction is more conservative than a 10-fold reduction employed in PNECs developed by Bengtsson-Palme and Larsson (<xref rid="c8" ref-type="bibr">8</xref>), thus indicating worst-case conditions. Nevertheless, Bengtsson-Palme and Larsson also reported treatment plant effluent concentrations above PNECs (<xref rid="c8" ref-type="bibr">8</xref>) in 28&#x0025; of cases. These results in combination indicate likely selection of resistant strains given antibiotic exposure in a wide variety of human-impacted aquatic settings.</p>
</sec>
<sec id="s4c">
<title>Model scope, limitations, and future directions</title>
<p>The parsimonious analytical solution we developed addresses vertical gene transfer of antibiotic resistance in a well-mixed environment as a function of fitness loss, competition, and antibiotic concentration. There are many aspects of resistance dissemination that fall outside the scope of this simple exercise, including horizontal gene transfer, interactions among multiple strains, spatial arrangement of individual colonies, and heterogeneity in antibiotic exposure due to biofilms and other mechanisms (<xref rid="c2" ref-type="bibr">2</xref>, <xref rid="c8" ref-type="bibr">8</xref>, <xref rid="c11" ref-type="bibr">11</xref>, <xref rid="c20" ref-type="bibr">20</xref>, <xref rid="c51" ref-type="bibr">51</xref>). Additionally, the model operates on and describes the long-term competition dynamics between bacterial strains, rather than stochastic and dynamic changes in net growth and competition over time. Thus, the derivation assumes that the parameters governing growth (e.g., R<sub>int</sub>, D<sub>int</sub>, D<sub>ab</sub>) will reach relatively stable values when one strain outcompetes another strain. This simplified model does not include parameters for the inoculum effect, biphasic killing, delay functions, drug concentration changes, drug-insusceptible persister cells, or adaptive resistance, all of which may occur in experimental settings. More sophisticated pharmacokinetic-pharmacodynamic models, which incorporate these processes are needed to characterize the bacterial time-kill curve and optimal dosing regimens (<xref rid="c21" ref-type="bibr">21</xref>&#x2013;<xref rid="c23" ref-type="bibr">23</xref>). However, such models do not lend themselves to an analytical solution similar to what we have provided. Investigation of varying initial ratios of resistant versus susceptible bacteria indicate no effect on selection coefficient, suggesting a limited importance of initial conditions, such as inoculum effect (<xref rid="c12" ref-type="bibr">12</xref>, <xref rid="c16" ref-type="bibr">16</xref>). Nevertheless, theoretical and experimental investigation of how short-term growth and killing and other dynamic processes would impact the MSC/MIC ratio is warranted in future studies, as is comparison of alternative models.</p>
<p>The primary benefit of the present model is in illustrating the MSC paradigm and the key drivers of selection in simplified systems. As such, this paper adds to the growing scientific understanding on how to interpret laboratory data on the MIC and other parameters for predicting the emergence of resistance at subinhibitory environmental concentrations. It highlights the value of characterizing the antibiotic dose-response (i.e., the Hill Coefficient &#x03BA;), particularly at antibiotic concentrations below the MIC. Ultimately, this quantification of resistance selection must be integrated into a risk assessment framework that also considers environmental antibiotic contamination, human exposure to and colonization by resistant bacteria, and the association between colonization and infection (<xref rid="c1" ref-type="bibr">1</xref>). Such a framework can help quantify the global hazard posed by antimicrobial agents.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This research has been partly carried out as part of the SUBMERGE program at University of Michigan, with support of the Graham Environmental Sustainability Institute at University of Michigan. BG was supported by a US EPA STAR Fellowship (Environmental Protection Agency FP917287) and a SAGE-IGERT traineeship (National Science Foundation Award Number 1144885). We thank Scott Reed for performing valuable analyses, and Peter Adriaens, Cedric Wannaz (University of Michigan) and Lee Riley (UC Berkeley) for helpful comments and input. Review by Lee Riley, John Balmes, and three anonymous reviewers greatly improved a previous version of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Ashbolt</surname> <given-names>NJ</given-names></string-name>, <string-name><surname>Am&#x00E9;zquita</surname> <given-names>A</given-names></string-name>, <string-name><surname>Backhaus</surname> <given-names>T</given-names></string-name>, <string-name><surname>Borriello</surname> <given-names>P</given-names></string-name>, <string-name><surname>Brandt</surname> <given-names>KK</given-names></string-name>, <string-name><surname>Collignon</surname> <given-names>P</given-names></string-name>, <string-name><surname>Coors</surname> <given-names>A</given-names></string-name>, <string-name><surname>Finley</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gaze</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Heberer</surname> <given-names>T</given-names></string-name>, <string-name><surname>Lawrence</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Larsson</surname> <given-names>DGJ</given-names></string-name>, <string-name><surname>McEwen</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Ryan</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Sch&#x00F6;nfeld</surname> <given-names>J</given-names></string-name>, <string-name><surname>Silley</surname> <given-names>P</given-names></string-name>, <string-name><surname>Snape</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Van den Eede</surname> <given-names>C</given-names></string-name>, <string-name><surname>Topp</surname> <given-names>E.</given-names></string-name> <year>2013</year>. <article-title>Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistance</article-title>. <source>Environ Health Perspect</source> <volume>121</volume>:<fpage>993</fpage>&#x2013;<lpage>1001</lpage>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Lupo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Coyne</surname> <given-names>S</given-names></string-name>, <string-name><surname>Berendonk</surname> <given-names>TU</given-names></string-name>. <year>2012</year>. <article-title>Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies</article-title>. <source>Front Microbiol</source> 2012/02/04. <volume>3</volume>:<fpage>18</fpage> pp.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Sarmah</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Boxall</surname> <given-names>ABA</given-names></string-name>. <year>2006</year>. <article-title>A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment</article-title>. <source>Chemosphere</source> <volume>65</volume>:<fpage>725</fpage>&#x2013;<lpage>759</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Tello</surname> <given-names>A</given-names></string-name>, <string-name><surname>Austin</surname> <given-names>B</given-names></string-name>, <string-name><surname>Telfer</surname> <given-names>TC</given-names></string-name>. <year>2012</year>. <article-title>Selective pressure of antibiotic pollution on bacteria of importance to public health</article-title>. <source>Environ Health Perspect2012/05/11</source>. <volume>120</volume>:<fpage>1100</fpage>&#x2013;<lpage>1106</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Martinez</surname> <given-names>JL</given-names></string-name>. <year>2009</year>. <article-title>Environmental pollution by antibiotics and by antibiotic resistance determinants</article-title>. <source>Environ Pollut</source> <volume>157</volume>:<fpage>2893</fpage>&#x2013;<lpage>2902</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Drlica</surname> <given-names>K.</given-names></string-name> <year>2002</year>. <article-title>Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window</article-title>. <source>J Infect Dis</source> <volume>185</volume>:<fpage>561</fpage>&#x2013;<lpage>565</lpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Drlica</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>X.</given-names></string-name> <year>2007</year>. <article-title>Mutant selection window hypothesis updated</article-title>. <source>Clin Infect Dis</source> <volume>44</volume>:<fpage>681</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Bengtsson-Palme</surname> <given-names>J</given-names></string-name>, <string-name><surname>Larsson</surname> <given-names>DGJ</given-names></string-name>. <year>2016</year>. <article-title>Concentrations of antibiotics predicted to select for resistant bacteria: Proposed limits for environmental regulation</article-title>. <source>Environ Int</source> <volume>86</volume>:<fpage>140</fpage>&#x2013;<lpage>149</lpage>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Firsov</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Smirnova</surname> <given-names>M V.</given-names></string-name>, <string-name><surname>Lubenko</surname> <given-names>IY</given-names></string-name>, <string-name><surname>Vostrov</surname> <given-names>SN</given-names></string-name>, <string-name><surname>Portnoy</surname> <given-names>YA</given-names></string-name>, <string-name><surname>Zinner</surname> <given-names>SH</given-names></string-name>. <year>2006</year>. <article-title>Testing the mutant selection window hypothesis with <italic>Staphylococcus aureus</italic> exposed to daptomycin and vancomycin in an <italic>in vitro</italic> dynamic model</article-title>. <source>J Antimicrob Chemother</source> <volume>58</volume>:<fpage>1185</fpage>&#x2013;<lpage>1192</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Cui</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>W</given-names></string-name>, <string-name><surname>Drlica</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>X.</given-names></string-name> <year>2006</year>. <article-title>The mutant selection window in rabbits infected with <italic>Staphylococcus aureus.</italic></article-title> <source>J Infect Dis</source> <volume>194</volume>:<fpage>1601</fpage>&#x2013;<lpage>1608</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Andersson</surname> <given-names>DI</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>D.</given-names></string-name> <year>2012</year>. <article-title>Evolution of antibiotic resistance at non-lethal drug concentrations</article-title>. <source>Drug Resist Updat</source> <volume>15</volume>:<fpage>162</fpage>&#x2013;<lpage>172</lpage>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Gullberg</surname> <given-names>E</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>S</given-names></string-name>, <string-name><surname>Berg</surname> <given-names>OG</given-names></string-name>, <string-name><surname>Ilb&#x00E4;ck</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sandegren</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>D</given-names></string-name>, <string-name><surname>Andersson</surname> <given-names>DI</given-names></string-name>. <year>2011</year>. <article-title>Selection of resistant bacteria at very low antibiotic concentrations</article-title>. <source>PLoS Pathog</source> <volume>7</volume>:<fpage>e1002158</fpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fong</surname> <given-names>A</given-names></string-name>, <string-name><surname>Becket</surname> <given-names>E</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Tamae</surname> <given-names>C</given-names></string-name>, <string-name><surname>Medrano</surname> <given-names>L</given-names></string-name>, <string-name><surname>Maiz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wahba</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>KP</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hoffman</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Salih</surname> <given-names>A</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>JH</given-names></string-name>. <year>2011</year>. <article-title>Selective advantage of resistant strains at trace levels of antibiotics: A simple and ultrasensitive color test for detection of antibiotics and genotoxic agents</article-title>. <source>Antimicrob Agents Chemother</source> <volume>55</volume>:<fpage>1204</fpage>&#x2013;<lpage>1210</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>J&#x00F8;rgensen</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Wassermann</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jensen</surname> <given-names>P&#x00D8;</given-names></string-name>, <string-name><surname>Hengzuang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Molin</surname> <given-names>S</given-names></string-name>, <string-name><surname>H&#x00F8;iby</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ciofu</surname> <given-names>O.</given-names></string-name> <year>2013</year>. <article-title>Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of <italic>Pseudomonas aeruginosa.</italic></article-title> <source>Antimicrob Agents Chemother</source> <volume>57</volume>:<fpage>4215</fpage>&#x2013;<lpage>4221</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Day</surname> <given-names>T</given-names></string-name>, <string-name><surname>Huijben</surname> <given-names>S</given-names></string-name>, <string-name><surname>Read</surname> <given-names>AF</given-names></string-name>. <year>2015</year>. <article-title>Is selection relevant in the evolutionary emergence of drug resistance?</article-title> <source>Trends Microbiol</source> <volume>23</volume>:<fpage>126</fpage>&#x2013;<lpage>133</lpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Gullberg</surname> <given-names>E</given-names></string-name>, <string-name><surname>Albrecht</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Karlsson</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sandegren</surname> <given-names>L</given-names></string-name>, <string-name><surname>Andersson</surname> <given-names>DI</given-names></string-name>. <year>2014</year>. <article-title>Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals</article-title>. <source>Bio</source> <volume>5</volume>:<fpage>19</fpage>&#x2013;<lpage>23</lpage>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Fleming</surname> <given-names>GT</given-names></string-name>, <string-name><surname>McCarthy</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Colombet</surname> <given-names>N</given-names></string-name>, <string-name><surname>Patching</surname> <given-names>JW</given-names></string-name>. <year>2002</year>. <article-title>The effect of levofloxacin concentration on the development and maintenance of antibiotic-resistant clones of <italic>Escherichia coli</italic> in chemostat culture</article-title>. <source>J Ind Microbiol Biotechnol</source> <volume>29</volume>:<fpage>155</fpage>&#x2013;<lpage>62</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Westhoff</surname> <given-names>S</given-names></string-name>, <string-name><surname>van Leeuwe</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Qachach</surname> <given-names>O</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>van Wezel</surname> <given-names>GP</given-names></string-name>, <string-name><surname>Rozen</surname> <given-names>DE</given-names></string-name>. <year>2017</year>. <article-title>The evolution of no-cost resistance at sub-MIC concentrations of streptomycin in <italic>Streptomyces coelicolor.</italic></article-title> <source>ISME J</source> <volume>11</volume>:<fpage>1168</fpage>&#x2013;<lpage>1178</lpage>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Regoes</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Wiuff</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zappala</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Garner</surname> <given-names>KN</given-names></string-name>, <string-name><surname>Baquero</surname> <given-names>F</given-names></string-name>, <string-name><surname>Levin</surname> <given-names>BR</given-names></string-name>. <year>2004</year>. <article-title>Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens</article-title>. <source>Antimicrob Agents Chemother</source> <volume>48</volume>:<fpage>3670</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Opatowski</surname> <given-names>L</given-names></string-name>, <string-name><surname>Guillemot</surname> <given-names>D</given-names></string-name>, <string-name><surname>Boelle</surname> <given-names>PY</given-names></string-name>, <string-name><surname>Temime</surname> <given-names>L.</given-names></string-name> <year>2011</year>. <article-title>Contribution of mathematical modeling to the fight against bacterial antibiotic resistance</article-title>. <source>Curr Opin Infect Dis</source> <volume>24</volume>:<fpage>279</fpage>&#x2013;<lpage>287</lpage>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname> <given-names>EI</given-names></string-name>, <string-name><surname>Cars</surname> <given-names>O</given-names></string-name>, <string-name><surname>Friberg</surname> <given-names>LE</given-names></string-name>. <year>2011</year>. <article-title>Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization</article-title>. <source>Antimicrob Agents Chemother</source> <volume>55</volume>:<fpage>4619</fpage>&#x2013;<lpage>30</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Mohamed</surname> <given-names>AF</given-names></string-name>, <string-name><surname>Nielsen</surname> <given-names>EI</given-names></string-name>, <string-name><surname>Cars</surname> <given-names>O</given-names></string-name>, <string-name><surname>Friberg</surname> <given-names>LE</given-names></string-name>. <year>2012</year>. <article-title>Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants</article-title>. <source>Antimicrob Agents Chemother</source> <volume>56</volume>:<fpage>179</fpage>&#x2013;<lpage>188</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="book"><string-name><surname>Wu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sy</surname> <given-names>SKB</given-names></string-name>, <string-name><surname>Derendorf</surname> <given-names>H.</given-names></string-name> <year>2014</year>. <chapter-title>Principles of applied pharmacokinetic&#x2013;pharmacodynamic modeling</chapter-title>, p. <fpage>63</fpage>&#x2013;<lpage>79</lpage>. <italic>In</italic> <person-group person-group-type="editor"><string-name><surname>Vinks</surname>, <given-names>AA</given-names></string-name>, <string-name><surname>Derendorf</surname>, <given-names>H</given-names></string-name>, <string-name><surname>Mouton</surname>, <given-names>JW</given-names></string-name></person-group> (eds.), <source>Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. Springer</source>, <publisher-loc>New York, NY</publisher-loc>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Melnyk</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kassen</surname> <given-names>R.</given-names></string-name> <year>2015</year>. <article-title>The fitness costs of antibiotic resistance mutations</article-title>. <source>Evol Appl</source> <volume>8</volume>:<fpage>273</fpage>&#x2013;<lpage>283</lpage>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><given-names>Komp</given-names> <surname>Lindgren</surname></string-name> P, <string-name><surname>Marcusson</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Sandvang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Frimodt-M&#x00F8;ller</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>D.</given-names></string-name> <year>2005</year>. <article-title>Biological cost of single and multiple norfloxacin resistance mutations in <italic>Escherichia coli</italic> implicated in urinary tract infections</article-title>. <source>Antimicrob Agents Chemother</source> <volume>49</volume>:<fpage>2343</fpage>&#x2013;<lpage>51</lpage>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Marcusson</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Frimodt-M&#x00F8;ller</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>D.</given-names></string-name> <year>2009</year>. <article-title>Interplay in the selection of fluoroquinolone resistance and bacterial fitness</article-title>. <source>PLoS Pathog</source> <volume>5</volume>:<fpage>e1000541</fpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Kishii</surname> <given-names>R</given-names></string-name>, <string-name><surname>Takei</surname> <given-names>M.</given-names></string-name> <year>2009</year>. <article-title>Relationship between the expression of <italic>ompF</italic> and quinolone resistance in <italic>Escherichia coli.</italic></article-title> <source>J Infect Chemother</source> <volume>15</volume>:<fpage>361</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Schrag</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Perrot</surname> <given-names>V</given-names></string-name>, <string-name><surname>Levin</surname> <given-names>BR</given-names></string-name>. <year>1997</year>. <article-title>Adaptation to the fitness costs of antibiotic resistance in <italic>Escherichia coli.</italic></article-title> <source>Proc Biol Sci</source> <volume>264</volume>:<fpage>1287</fpage>&#x2013;<lpage>91</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Andersson</surname> <given-names>DI</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>D.</given-names></string-name> <year>2010</year>. <article-title>Antibiotic resistance and its cost: is it possible to reverse resistance?</article-title> <source>Nat Rev Microbiol</source> <volume>8</volume>:<fpage>260</fpage>&#x2013;<lpage>271</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Austin</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>RM</given-names></string-name>. <year>1999</year>. <article-title>Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models</article-title>. <source>Philos Trans R Soc Lond B Biol Sci1999/06/12</source>. <volume>354</volume>:<fpage>721</fpage>&#x2013;<lpage>38</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Goutelle</surname> <given-names>S</given-names></string-name>, <string-name><surname>Maurin</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rougier</surname> <given-names>F</given-names></string-name>, <string-name><surname>Barbaut</surname> <given-names>X</given-names></string-name>, <string-name><surname>Bourguignon</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ducher</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maire</surname> <given-names>P.</given-names></string-name> <year>2008</year>. <article-title>The Hill equation: a review of its capabilities in pharmacological modelling</article-title>. <source>Fundam Clin Pharmacol</source> <volume>22</volume>:<fpage>633</fpage>&#x2013;<lpage>648</lpage>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Mouton</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Vinks</surname> <given-names>AA</given-names></string-name>. <year>2005</year>. <article-title>Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration</article-title>. <source>Clin Pharmacokinet</source> <volume>44</volume>:<fpage>201</fpage>&#x2013;<lpage>210</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Ankomah</surname> <given-names>P</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>PJTP</given-names></string-name>, <string-name><surname>Levin</surname> <given-names>BR</given-names></string-name>. <year>2013</year>. <article-title>The pharmaco&#x2013;, population and evolutionary dynamics of multi-drug therapy: experiments with <italic>S. aureus</italic> and <italic>E. coli</italic> and computer simulations</article-title>. <source>PLoS Pathog</source> <volume>9</volume>:<fpage>e1003300</fpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Kahlmeter</surname> <given-names>G</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>DFJ</given-names></string-name>, <string-name><surname>Goldstein</surname> <given-names>FW</given-names></string-name>, <string-name><surname>MacGowan</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Mouton</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Osterlund</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rodloff</surname> <given-names>A</given-names></string-name>, <string-name><surname>Steinbakk</surname> <given-names>M</given-names></string-name>, <string-name><surname>Urbaskova</surname> <given-names>P</given-names></string-name>, <string-name><surname>Vatopoulos</surname> <given-names>A.</given-names></string-name> <year>2003</year>. <article-title>European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria</article-title>. <source>J Antimicrob Chemother</source> <volume>52</volume>:<fpage>145</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Levin</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Perrot</surname> <given-names>V</given-names></string-name>, <string-name><surname>Walker</surname> <given-names>N.</given-names></string-name> <year>2000</year>. <article-title>Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria</article-title>. <source>Genetics</source> <volume>154</volume>:<fpage>985</fpage>&#x2013;<lpage>997</lpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Mellefont</surname> <given-names>LA</given-names></string-name>, <string-name><surname>McMeekin</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Ross</surname> <given-names>T.</given-names></string-name> <year>2003</year>. <article-title>Performance evaluation of a model describing the effects of temperature, water activity, pH and lactic acid concentration on the growth of <italic>Escherichia coli.</italic></article-title> <source>Int J Food Microbiol</source> <volume>82</volume>:<fpage>45</fpage>&#x2013;<lpage>58</lpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Baker-Austin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wright</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Stepanauskas</surname> <given-names>R</given-names></string-name>, <string-name><surname>McArthur</surname> <given-names>J V.</given-names></string-name> <year>2006</year>. <article-title>Co-selection of antibiotic and metal resistance</article-title>. <source>Trends Microbiol</source> <volume>14</volume>:<fpage>176</fpage>&#x2013;<lpage>182</lpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Seiler</surname> <given-names>C</given-names></string-name>, <string-name><surname>Berendonk</surname> <given-names>TU</given-names></string-name>. <year>2012</year>. <article-title>Heavy metal driven co-selection of antibiotic resistance in soil and water bodies impacted by agriculture and aquaculture</article-title>. <source>Front Microbiol</source> <volume>3</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Wold</surname> <given-names>S.</given-names></string-name> <year>1991</year>. <article-title>Validation of QSAR&#x0027;s</article-title>. <source>Quant Struct Relationships</source> <volume>10</volume>:<fpage>191</fpage>&#x2013;<lpage>193</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Wiuff</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zappala</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Regoes</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Garner</surname> <given-names>KN</given-names></string-name>, <string-name><surname>Baquero</surname> <given-names>F</given-names></string-name>, <string-name><surname>Levin</surname> <given-names>BR</given-names></string-name>. <year>2005</year>. <article-title>Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations</article-title>. <source>Antimicrob Agents Chemother</source> <volume>49</volume>:<fpage>1483</fpage>&#x2013;<lpage>94</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Molbak</surname> <given-names>K.</given-names></string-name> <year>2004</year>. <article-title>Spread of resistant bacteria and resistance genes from animals to humans - the public health consequences</article-title>. <source>J Vet Med Ser B-Infectious Dis Vet Public Heal</source> <volume>51</volume>:<fpage>364</fpage>&#x2013;<lpage>369</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Luo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Rysz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Alvarez</surname> <given-names>PJJ</given-names></string-name>. <year>2011</year>. <article-title>Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River basin, China</article-title>. <source>Environ Sci Technol</source> <volume>45</volume>:<fpage>1827</fpage>&#x2013;<lpage>1833</lpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Kolpin</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Furlong</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Thurman</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Zaugg</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Barber</surname> <given-names>LB</given-names></string-name>, <string-name><surname>Buxton</surname> <given-names>HT</given-names></string-name>. <year>2002</year>. <article-title>Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance</article-title>. <source>Environ Sci Technol</source> <volume>36</volume>:<fpage>1202</fpage>&#x2013;<lpage>1211</lpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Fick</surname> <given-names>J</given-names></string-name>, <string-name><surname>S&#x00F6;derstr&#x00F6;m</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lindberg</surname> <given-names>RH</given-names></string-name>, <string-name><surname>Phan</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tysklind</surname> <given-names>M</given-names></string-name>, <string-name><surname>Larsson</surname> <given-names>DGJ</given-names></string-name>. <year>2009</year>. <article-title>Contamination of surface, ground, and drinking water from pharmaceutical production</article-title>. <source>Environ Toxicol Chem</source> <volume>28</volume>:<fpage>2522</fpage>&#x2013;<lpage>2527</lpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>S</given-names></string-name>, <string-name><surname>Aga</surname> <given-names>DS</given-names></string-name>. <year>2007</year>. <article-title>Potential ecological and human health impacts of antibiotics and antibiotic-resistant bacteria from wastewater treatment plants</article-title>. <source>J Toxicol Environ Heal B-Critical Rev</source> <volume>10</volume>:<fpage>559</fpage>&#x2013;<lpage>573</lpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Vogelman</surname> <given-names>B</given-names></string-name>, <string-name><surname>Craig</surname> <given-names>WA</given-names></string-name>. <year>1986</year>. <article-title>Kinetics of antimicrobial activity</article-title>. <source>J Pediatr</source> <volume>108</volume>:<fpage>835</fpage>&#x2013;<lpage>840</lpage>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Daikos</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Lolans</surname> <given-names>VT</given-names></string-name>, <string-name><surname>Livermore</surname> <given-names>DM</given-names></string-name>. <year>1990</year>. <article-title>Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation</article-title>. <source>J Infect Dis</source> <volume>162</volume>:<fpage>414</fpage>&#x2013;<lpage>420</lpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Barclay</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Begg</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Chambers</surname> <given-names>ST</given-names></string-name>. <year>1992</year>. <article-title>Adaptive resistance following single doses of gentamicin in a dynamic in vitro model</article-title>. <source>Antimicrob Agents Chemother</source> <volume>36</volume>:<fpage>1951</fpage>&#x2013;<lpage>1957</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Hocquet</surname> <given-names>D</given-names></string-name>, <string-name><surname>Vogne</surname> <given-names>C</given-names></string-name>, <string-name><surname>Garch F</surname> <given-names>El</given-names></string-name>, <string-name><surname>Gotoh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lomovskaya</surname> <given-names>O</given-names></string-name>, <string-name><surname>Vejux</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ple</surname> <given-names>P.</given-names></string-name> <year>2003</year>. <article-title>MexXY-OprM efflux pump is necessary for adaptive resistance of <italic>Pseudomonas aeruginosa</italic> to aminoglycosides</article-title>. <source>Antimicrob Agents Chemother</source> <volume>47</volume>:<fpage>1371</fpage>&#x2013;<lpage>1375</lpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Gould</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Milne</surname> <given-names>K</given-names></string-name>, <string-name><surname>Harvey</surname> <given-names>G</given-names></string-name>, <string-name><surname>Jason</surname> <given-names>C.</given-names></string-name> <year>1991</year>. <article-title>Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin</article-title>. <source>J Antimicrob Chemother</source> <volume>27</volume>:<fpage>741</fpage>&#x2013;<lpage>748</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Stewart</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Franklin</surname> <given-names>MJ</given-names></string-name>. <year>2008</year>. <article-title>Physiological heterogeneity in biofilms</article-title>. <source>Nat Rev Microbiol</source> <volume>6</volume>:<fpage>199</fpage>&#x2013;<lpage>210</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>